Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa

- Media Contacts: Jake Sargent +1 732-524-1090 JSargen3@its.jnj.com Seema Kumar +1 908-405-1144 SKumar10@its.jnj.com Caitlin Wheeler +31 61547 6410 Cwheele7@its.jnj.com Investor Relations: Jennifer McIntyre +1 732-524-3922